NO934834D0 - 2-Amino-6,7-dihydroksy-4 tiaheptasyrederivater, fremstilling og a nvendelse av disse - Google Patents

2-Amino-6,7-dihydroksy-4 tiaheptasyrederivater, fremstilling og a nvendelse av disse

Info

Publication number
NO934834D0
NO934834D0 NO934834A NO934834A NO934834D0 NO 934834 D0 NO934834 D0 NO 934834D0 NO 934834 A NO934834 A NO 934834A NO 934834 A NO934834 A NO 934834A NO 934834 D0 NO934834 D0 NO 934834D0
Authority
NO
Norway
Prior art keywords
amino
amino acid
thiazeptic
dihydroxy
preparation
Prior art date
Application number
NO934834A
Other languages
English (en)
Other versions
NO934834L (no
Inventor
Seiichi Tanida
Tsuneaki Hida
Mitsuhiro Wakimasu
Setsuo Harada
Koichi Yukishige
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO934834D0 publication Critical patent/NO934834D0/no
Publication of NO934834L publication Critical patent/NO934834L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO934834A 1992-12-28 1993-12-27 2-amino-6,7-dihydroksy-4-tiaheptasyrederivater, fremstilling og anvendelse av disse NO934834L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP34906292 1992-12-28
JP5618593 1993-03-16
JP18173593 1993-07-22

Publications (2)

Publication Number Publication Date
NO934834D0 true NO934834D0 (no) 1993-12-27
NO934834L NO934834L (no) 1994-06-29

Family

ID=27295829

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934834A NO934834L (no) 1992-12-28 1993-12-27 2-amino-6,7-dihydroksy-4-tiaheptasyrederivater, fremstilling og anvendelse av disse

Country Status (15)

Country Link
US (1) US5478808A (no)
EP (1) EP0604957B1 (no)
KR (1) KR940014436A (no)
CN (1) CN1094731A (no)
AT (1) ATE170871T1 (no)
AU (1) AU666789B2 (no)
CA (1) CA2112523A1 (no)
DE (1) DE69320931T2 (no)
FI (1) FI935888A (no)
HU (1) HUT65865A (no)
IL (1) IL108173A (no)
NO (1) NO934834L (no)
NZ (1) NZ250588A (no)
PH (1) PH30687A (no)
TW (1) TW264479B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1313754A4 (en) * 2000-09-01 2006-09-27 Gryphon Therapeutics Inc COMPOSITIONS PRODUCING STABLE THIOESTERS WITH OPHILIC NUCL, PROCESSES FOR PRODUCTION AND USE
EP1382352A1 (de) * 2002-07-19 2004-01-21 GBF Gesellschaft für Biotechnologische Forschung mbH Bisacyloxypropylcystein-Konjugate und deren Verwendung
DE102005024040A1 (de) * 2005-05-25 2006-12-14 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetisches oder therapeutisches Kombinationspräparat mit Theanin
WO2006138238A2 (en) * 2005-06-13 2006-12-28 Cleveland Biolabs, Inc. Methods of protecting against apoptosis using lipopeptides
CN101421293B (zh) 2006-03-01 2013-09-25 福冈县政府 含有肽脂质的载体和使用该载体将化合物引入细胞的方法
DE102009034779A1 (de) * 2009-07-25 2011-02-03 Emc Microcollections Gmbh Synthetische Analoga bakterieller Lipopeptide und ihre Anwendung zur Therapie und Prophylaxe allergischer Erkrankungen
EA023725B1 (ru) * 2010-03-23 2016-07-29 Новартис Аг Соединения (липопептиды на основе цистеина) и композиции в качестве агонистов tlr2, применяемые для лечения инфекционных, воспалительных, респираторных и других заболеваний

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000330B1 (de) * 1977-06-20 1981-08-05 Ciba-Geigy Ag Lipopeptide, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Präparate
EP0014815A3 (de) * 1978-12-20 1980-10-29 Ciba-Geigy Ag Peptidderivate, Verfahren zu deren Herstellung und Zwischenprodukte sowie pharmazeutische Präparate mit einer dieser Verbindungen
ATE67769T1 (de) * 1983-01-25 1991-10-15 Ciba Geigy Ag Neue peptidderivate.
DE3546150A1 (de) * 1985-06-24 1987-01-22 Hoechst Ag Membrananker-wirkstoffkonjugat, seine herstellung sowie seine verwendung
JPH0446194A (ja) * 1990-06-13 1992-02-17 Fujisawa Pharmaceut Co Ltd Ｗｓ１２７９ａ物質、その生産法及び用途
JPH0499796A (ja) * 1990-08-13 1992-03-31 Kazuo Achinami 新規リポペプタイド及び抗腫瘍剤
ATE147404T1 (de) * 1991-12-19 1997-01-15 Ciba Geigy Ag Aminosulfonsäurederivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
US5478808A (en) 1995-12-26
DE69320931D1 (de) 1998-10-15
PH30687A (en) 1997-09-16
EP0604957B1 (en) 1998-09-09
DE69320931T2 (de) 1999-05-20
AU666789B2 (en) 1996-02-22
IL108173A (en) 1998-03-10
HUT65865A (en) 1994-07-28
CA2112523A1 (en) 1994-06-29
EP0604957A1 (en) 1994-07-06
AU5261493A (en) 1994-07-07
TW264479B (no) 1995-12-01
FI935888A (fi) 1994-06-29
NO934834L (no) 1994-06-29
NZ250588A (en) 1995-03-28
KR940014436A (ko) 1994-07-18
HU9303761D0 (en) 1994-04-28
CN1094731A (zh) 1994-11-09
FI935888A0 (fi) 1993-12-27
IL108173A0 (en) 1994-04-12
ATE170871T1 (de) 1998-09-15

Similar Documents

Publication Publication Date Title
IE811566L (en) Steel articles protected against corrosion.
ATE136882T1 (de) Carbamidsäureester-derivate, mittel und herstellungsverfahren
BR9508037A (pt) Derivados de piridona-ácido carboxilico agente anti-tumor composição farmacológica e processo para preparar derivados de piridona-ácido carboxilico
GB2091723B (en) Derivatives of 2-oxoazetidine-1-sulphonic acid
NO934834D0 (no) 2-Amino-6,7-dihydroksy-4 tiaheptasyrederivater, fremstilling og a nvendelse av disse
AU683790B2 (en) Nitric esters from derivatives of 2-(2-6-dihalophenylamino) phenylacetoxyacetic acid and their preparation process
PT89935A (pt) Processo para a preparacao de novos compostos cefem
PT99043A (pt) Processo para a preparacao de composicoes biocidas contendo derivados de 4,5-polimetileno-4-isotiazolin-3-onas
EA200001107A1 (ru) ПРОИЗВОДНЫЕ ОКТАГИДРО-6,10-ДИОКСО-6H-ПИРИДАЗИНО [1,2-a] [1,2] ДИАЗЕПИН-1-КАРБОНОВОЙ КИСЛОТЫ, СПОСОБ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ ДЛЯ ПОЛУЧЕНИЯ ТЕРАПЕВТИЧЕСКИ АКТИВНЫХ СОЕДИНЕНИЙ
BR9103415A (pt) Derivados de halogenoalquil-azolila,processo para sua preparacao,composicoes microbicidas,emprego e processos para o combate de microorganismos indesejados e para a preparacao de composicoes
NO931716D0 (no) Fremgangsmaate for fremstilling av n,n-dialkylglycaminforbindelser
ATE44741T1 (de) 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere.